OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Earlier this week, he unveiled perhaps the most ambitious infrastructure project in history—and all but dedicated it to Sam ...
Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...
Sam Altman's OpenAI is backing a new AI initiative from a group where John Kerry was a founding member that has voiced ...
As an example of how the tech could be used to complete everyday tasks, Altman and a group of OpenAI researchers uploaded an ...
Retro Biosciences is raising $1 billion, with the ultimate goal of using its customized AI to extend human lifespan by 10 ...